Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-23-038945

Chief Executive Officer sold 75,810 shares at an average $17.12 ($1,297,542)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Harris Todd Chief Executive Officer 2023-06-16 Sale 10b5-1 −3,316 $16.49 $54,681 1,697,960 D
Harris Todd Chief Executive Officer 2023-06-16 Sale 10b5-1 −50,838 $17.06 $867,296 1,647,122 D
Harris Todd Chief Executive Officer 2023-06-16 Sale 10b5-1 −600 $18.50 $11,100 1,646,522 D
Harris Todd Chief Executive Officer 2023-06-20 Sale 10b5-1 −1,300 $16.53 $21,493 1,645,222 D
Harris Todd Chief Executive Officer 2023-06-21 Sale 10b5-1 −4,629 $16.12 $74,615 1,640,593 D
Harris Todd Chief Executive Officer 2023-06-21 Sale 10b5-1 −14,027 $17.71 $248,358 1,626,566 D
Harris Todd Chief Executive Officer 2023-06-21 Sale 10b5-1 −1,100 $18.18 $19,999 1,625,466 D
Open-market sales · 75,810 sh · avg $17.12 · $1,297,542
Loading xslF345X04/doc4.xml…